Patents by Inventor William J. Suling

William J. Suling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of FtsZ and uses thereof
    Patent number: 7718651
    Abstract: The invention relates to inhibitors of FtsZ polymerization and uses thereof.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: May 18, 2010
    Assignee: Southern Research Institute
    Inventors: E. Lucile White, Robert C. Reynolds, William J. Suling
  • INHIBITORS OF FTSZ AND USES THEREOF
    Publication number: 20100113429
    Abstract: The invention relates to inhibitors of FtsZ polymerization and uses thereof.
    Type: Application
    Filed: December 31, 2009
    Publication date: May 6, 2010
    Inventors: E. Lucile White, Robert C. Reynolds, William J. Suling
  • Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase
    Patent number: 6559295
    Abstract: The invention relates to the nucleic acid sequence and amino acid sequence of dihydrofolate reductase (DHFR) from mycobacteria and to expression of recombinant DHFR protein. Utilizing the recombinant protein, novel therapies and diagnostic strategies can be developed and selective antimycobacterial compositions can be designed and utilized to treat mycobacterial infections in patients. This invention includes all or portions of novel recombinant nucleic acids encoding DHFR for mycobacteria such as M. avium, to novel recombinant DHFR peptides produced by such sequences, and to vaccines, diagnostic kits, cells and therapies utilizing these peptides and nucleic acid sequences. The present invention relates to methods for using the sequences of the present invention to develop drugs specific to M. avium and other mycobacteria, to identify and sequence corresponding sequences in species other than M. avium, as well as diagnostic and treatment methods incorporating the disclosed sequences and peptides.
    Type: Grant
    Filed: August 12, 1999
    Date of Patent: May 6, 2003
    Assignee: Southern Research Institute
    Inventors: William W. Barrow, Sabrina Z. Van Ginkel, Thomas P. Dooley, William J. Suling
  • Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
    Patent number: 6229001
    Abstract: The invention relates to the nucleic acid sequence and amino acid sequence of dihydrofolate reductase (DHFR) from mycobacteria and to expression of recombinant DHFR protein. Utilizing the recombinant protein, novel therapies and diagnostic strategies can be developed and selective antimycobacterial compositions can be designed and utilized to treat mycobacterial infections in patients. This invention includes all or portions of novel recombinant nucleic acids encoding DHFR for mycobacteria such as M. avium, to novel recombinant DHFR peptides produced by such sequences, and to vaccines, diagnostic kits, cells and therapies utilizing these peptides and nucleic acid sequences. The present invention relates to methods for using the sequences of the present invention to develop drugs specific to M. avium and other mycobacteria, to identify and sequence corresponding sequences in species other than M. avium, as well as diagnostic and treatment methods incorporating the disclosed sequences and peptides.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: May 8, 2001
    Assignee: Southern Research Institute
    Inventors: William W. Barrow, Sabrina Z. Van Ginkel, Thomas P. Dooley, William J. Suling